| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a348e26c1de02ede1eb5c47bb3eb1979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd5e7c2f112605fcd410141b0c4f2ebc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a3311458066992ab5029ed1da8c5685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2b6b9c313d7f6a8ca700985d15b3cc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ab2d714181eae13dd7cdead6e6fdaf3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cf0b755988e521c76343bc3f09d40a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30b31aa968add4d396f36dcfa67b1b31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb2066f66557fd0a4ec541f73e95262
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d66dcf899fd8fe5dc551f1785ca59ba |
| publicationDate |
2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8119601-B2 |
| titleOfInvention |
Voltage dependent anion channel (VDAC1) compositions and methods of use thereof for regulating apoptosis |
| abstract |
The present invention relates generally to the mitochondrial protein, voltage-dependent anion channel (VDAC)5 polynucleotides encoding same and variants thereof, as well as peptide fragments, peptide derivatives and analogs. In particular, the present invention is directed to VDAC1 and specific amino acid and polynucleotide sequences thereof useful in inducing or regulating apoptosis and to pharmaceutical compositions comprising same useful in the treatment of diseases associated with aberrant apoptosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021152579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758559-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015011711-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017037711-A1 |
| priorityDate |
2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |